000182684 001__ 182684
000182684 005__ 20240229145727.0
000182684 0247_ $$2doi$$a10.1016/j.canep.2022.102282
000182684 0247_ $$2pmid$$apmid:36395613
000182684 0247_ $$2ISSN$$a1877-7821
000182684 0247_ $$2ISSN$$a1877-783X
000182684 037__ $$aDKFZ-2022-02852
000182684 041__ $$aEnglish
000182684 082__ $$a610
000182684 1001_ $$aGali, Kathleen$$b0
000182684 245__ $$aChanges in cigarette smoking behavior among breast cancer and unaffected women - A prospective study in the MARIE cohort.
000182684 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2022
000182684 3367_ $$2DRIVER$$aarticle
000182684 3367_ $$2DataCite$$aOutput Types/Journal article
000182684 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1668784008_5814
000182684 3367_ $$2BibTeX$$aARTICLE
000182684 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182684 3367_ $$00$$2EndNote$$aJournal Article
000182684 500__ $$a#LA:C020#
000182684 520__ $$aSmoking cessation after a cancer diagnosis can reduce adverse cancer treatment outcomes. Whether a breast cancer diagnosis, a cancer commonly seen as unrelated to smoking cigarettes, motivates changes in smoking behavior is not fully understood. We aimed to compare long-term changes at three follow-up times of cigarette smoking behavior in women with breast cancer and baseline age- and region-matched unaffected women.We used longitudinal data from the population-based case-control study MARIE (Mamma Carcinoma Risk Factor Investigation). Women with breast cancer (N = 3813) and unaffected women (N = 7341) aged 50-74 years were recruited from 2002 to 2005. Analyses on changes in smoking were based on data from those who also completed follow-up 1 in 2009-2012, follow-up 2 in 2014-2016 and follow-up 3 in 2020. Multinomial logistic regression for changes (quitting, stable, or start smoking) adjusted for age, study region, education, comorbidities, living situation, and follow-up time, was applied to examine the associations between breast cancer status and changes in smoking behavior.Women with breast cancer had significantly higher odds than unaffected women of quitting smoking (OR = 1.38, 95 % CI: 1.01-1.89) and lower odds of returning to smoking (OR = 0.29, 95 % CI: 0.09-0.94) at follow-up 1, but were more likely to start or return to smoking at follow-up 2 (OR = 2.11, 95 % CI 1.08-4.15). No significant group differences were found for changes in smoking behavior at follow-up 3.Our findings indicate that short-term changes in smoking behavior can be attributed to a breast cancer diagnosis, but that over time the effect diminishes and changes in smoking no longer differ between breast cancer and breast cancer-free women. To support smoking cessation and to prevent relapse, guidelines to address smoking in cancer care, as well as comprehensive tobacco treatment services, are needed.
000182684 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000182684 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000182684 650_7 $$2Other$$aBehavior change
000182684 650_7 $$2Other$$aBreast cancer
000182684 650_7 $$2Other$$aSmoking
000182684 650_7 $$2Other$$aTobacco
000182684 7001_ $$aBokemeyer, Frederike$$b1
000182684 7001_ $$0P:(DE-He78)6b04712f3afe72044d496a25505cb1ea$$aBehrens, Sabine$$b2$$udkfz
000182684 7001_ $$aMöhl, Annika$$b3
000182684 7001_ $$aObi, Nadia$$b4
000182684 7001_ $$aBecher, Heiko$$b5
000182684 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b6$$eLast author$$udkfz
000182684 773__ $$0PERI:(DE-600)2498032-8$$a10.1016/j.canep.2022.102282$$gVol. 81, p. 102282 -$$p102282$$tCancer epidemiology$$v81$$x1877-7821$$y2022
000182684 909CO $$ooai:inrepo02.dkfz.de:182684$$pVDB
000182684 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6b04712f3afe72044d496a25505cb1ea$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000182684 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000182684 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000182684 9141_ $$y2022
000182684 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000182684 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000182684 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000182684 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEMIOL : 2021$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-18
000182684 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000182684 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000182684 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000182684 980__ $$ajournal
000182684 980__ $$aVDB
000182684 980__ $$aI:(DE-He78)C020-20160331
000182684 980__ $$aUNRESTRICTED